Fig. 2From: Telmisartan in the diabetic murine model of acute myocardial infarction: dual contrast manganese-enhanced and delayed enhancement MRI evaluation of the peri-infarct regionInvasive hemodynamic analysis. No significant difference is seen in the telmisartan-treated (red bar) diabetic mice compared to control diabetic mice (white bar) for both systemic end-diastolic pressure and the isovolumic relaxation constant, Tau, calculated by the Glantz methodBack to article page